What's new?

A high-ticket finance brand in Germany had dismissed Meta for them. Too broad. Wrong audience. We built a phased structure. Budget and targeting scaled progressively. Nearly three months of sustained delivery. 146 leads. $8,505 spent. $58.36 average CPL — controlled throughout. The assumption got disproven. The leads kept coming.

$34.42 per finance lead in Australia. Two months. Meta. Most campaigns in AU finance struggle to hold steady CPL as spend scales. We built a structure that held. Budget increased progressively over the campaign period. CPL stayed flat. 239 leads. No interruptions. No account issues.

Most brands find out what happened to their budget once a month. We send a structured weekly report to every client. Automatically. No follow-up needed. You see where your budget went. What drove performance. A four-week trend graph. Explicit next steps so you always know what's next. Same format every week. No chasing your account manager. No silence. Full visibility.

A Turkish gambling client was burning budget on Meta with nothing to show. Ads running, no conversions reporting, traffic quality tanking. The problem: Three tracking layers completely out of sync, optimizing for nothing. We identified the infrastructure gap and restored the conversion signal. Traffic quality followed. The campaign started working. This is the kind of problem most operators can't even diagnose.

Peptide ads on Meta? Most brands assume it's impossible. Here's why: Peptides cannot be sold or advertised for human use. That single constraint shapes everything. Your creatives, your copy, your lander, your entire funnel has to stay inside that boundary or you're looking at account bans, MATCH listing, and six-figure fines. We built creatives that are both platform-compliant and legally sound. We protected both brand presentation and account integrity. 9.75x ROAS on prospecting. 46 purchases under $40 each. Account stable. Compliant ads worked where most operators assume you cannot run.

Not every win shows up in a case study. Sometimes it's just five words from a founder who finally sees their numbers moving. "This ROAS is amazing." In the peptide space where most campaigns don't survive long enough to show results. Ours thrived The only request was to "scale harder". That's the kind of moment you share with the team.